Kraus Quoted on Rise in False Claim Act Cases Against Health Care Providers
30 September 2020
Partner Lawrence Kraus was quoted in a Medscape article, “Physicians Misjudge a Terminal Patient’s Life Span: Is It Fraud?” about whether a physician’s honestly held clinical judgment regarding hospice certification can be false under the False Claim Act based solely on a reasonable difference of opinion among physicians.
Kraus, who defends health care providers in FCA cases, said the issue is also important in FCA cases against other types of health care providers, including hospitals, because physicians make all kinds of clinical decisions that trigger payments by Medicare, Medicaid, and other government health insurance programs.
“This will spill over to many other types of physician clinical decisions,” he said. “Clinical judgment comes up in almost every instance because the Medicare statute requires that the service provided be reasonable and necessary.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”